Intel

Key Takeaways Rapid growth in regenerative and alternative therapies is expanding Healthcare Liability exposures across medspas and healthcare providers. Coverage considerations are multifaceted, with many carriers applying exclusions, limitations, and strict underwriting requirements for non-FDA-approved and off-label treatments. A complex regulatory environment, driven by both federal and state oversight, impacts how Healthcare Liability risks are evaluated and underwritten Many claims stem from insufficient informed consent, patient screening, and marketing practices…

Inadequate patient screening in Telehealth can create significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Kelli Bernstein, Inside Broker, Brokerage Division, Burns & Wilcox, Atlanta, Georgia, explains how gaps in screening and evaluation can lead to increased risk and potential claims. https://vimeo.com/1177366805/c08e5cfc77?share=copy&fl=sv&fe=ci

Regenerative and alternative therapies—such as peptides, NAD+, ketamine, and stem cells—are rapidly expanding across healthcare and medspa settings. While these treatments present new opportunities for providers, they also introduce complex Healthcare Liability exposures. Now available on demand, this webinar features experts from Burns & Wilcox and GenStar Insurance Services as they explore evolving standards of care, regulatory scrutiny, and coverage…